Together, these results demonstrate co-expression of these genes in human DRNVglut3 neurons, recapitulating our in situ results in mice (Extended Data Fig. 5d) and further that suggesting Hcrtr1-specific antagonism using CVN45502 could represent a potential therapeutic approach for treating obesity in people. Here, HCRTR1 is linked to obesity disorder.